This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Wientjes, M. H. M. et al. Drug levels, anti-drug antibodies and B-cell counts were not predictive of response in rheumatoid arthritis patients on low dose rituximab. Rheumatology https://doi.org/10.1093/rheumatology/keac024 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Phillips, R. Low-dose rituximab can go even lower. Nat Rev Rheumatol 18, 126 (2022). https://doi.org/10.1038/s41584-022-00757-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-022-00757-9